AMRX (Amneal Pharmaceuticals, Inc.) Gross Profit Margin

Corporate emblem and logo of Amneal Pharmaceuticals Inc (AMRX)

The gross margin trend reflects the impact of pricing pressure and debt obligations of Amneal Pharmaceuticals (AMRX). However, diversification through biosimilars minimizes patent threats, while demand for affordable therapy guarantees a steady cash flow. This price action confirms the business's operational efficiency, while 40.20 shows the current metric value, determining the real-time profitability of production.

amneal.com (AMRX) Gross Profitability: for the period 07/04/2022 - 11/20/2026

Analytical breakdowns and data insights for company Amneal Pharmaceuticals Inc (AMRX)

- stock quotes and analyst forecast:
- business market valuation indicators:
Fundamental valuation:Amneal (AMRX)
Manufactured products of Amneal Pharmaceuticals, Inc.

The gross margin dynamics of Amneal Pharmaceuticals (AMRX) reflect the efficiency of cost management during the market launch of complex biosimilars and injectable drugs. This indicator measures the profit share after deducting production costs, allowing investors to assess the business's pricing power and management's ability to maintain high product profitability over the long term.

Direct competitors

Gross Profit Margin Haleon PLC (HLN)|Return on Gross Profit KVUE|Gross Profit Margin Verona Pharma Inc. VRNA|Gross Margin MENS|Ligand Pharmaceuticals - Gross Return on Sales|Gross Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Gross Profit Margin|Liquidia Inc. - Gross Margin|Gross Sales Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Gross Profitability|Gross Return on Sales MNKD|Gross Profitability Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Return on Sales by Gross Profit|Gross Margin SPRY|TBPH - Gross Profit Margin|Aquestive Pharma - Return on Gross Profit|Gross Margin scpharmaceuticals.com SCPH|Tectonic - Gross Margin|TNXP - Gross Margin|SXTC: Gross Margin|Eupraxia Pharma - Gross Profit Rate|BHST (bioharvest.com) - Gross Margin|Gross Return on Sales EXOZ (invizyne.com)|Gross Margin ORMP|Return on Sales by Gross Profit Entera Bio|Gross Margin HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Gross Profitability|Cumberland Corp - Gross Margin|QNTM - Gross Margin|FibroGen, Inc. (FGEN) - Gross Profitability|TELO: Gross Profit Ratio|RANI (Rani Therapeutics Inc) - Gross Margin|Gross Profit Margin synergychc.com SNYR|Gross Profitability Rallybio Corp. (RLYB)|LEXX - Gross Profit Margin|Gross Margin PULM (pulmatrix.com)|Gross Profit Ratio PTHL (Pheton)|APM - Gross Profitability|Return on Sales by Gross Profit Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Gross Profitability|TNF Pharma (TNFA) - Gross Margin|YCBD (cbdmd.com) - Gross Margin|Return on Gross Profit PainReform (PRFX)|Gross Profitability Altamira Therapeutics (CYTO)|Return on Sales by Gross Profit Lipella Pharma|Optinose - Return on Gross Profit|Return on Sales by Gross Profit pieris.com (PIRS)|PROC - Gross Profitability|Gross Profitability Margin PTPI|QLI: Gross Margin|Gross Profit Margin ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Gross Margin